Search clinical trials for: T-DM1 adjuvant
Total 11787 results
-
Regina Elena Cancer InstituteRecruiting
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
DualityBio Inc.BioNTech SERecruiting
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
West German Study GroupRoche Pharma AGActive, not recruiting
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Ascension South East MichiganCompletedSkin InfectionUnited States
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
University of Texas Southwestern Medical CenterUniversity of Pennsylvania; PfizerCompletedAdvanced Breast CancerUnited States
-
Genentech, Inc.Completed
-
University of ArizonaPfizerCompletedBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | Recurrent Breast Cancer | HER2 Positive Breast Carcinoma | Breast Cancer StageUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu PositiveUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Canada, Spain, Belgium, China, Italy, Korea, Republic of, Taiwan, Australia, Japan, Brazil, France, Germany, United Kingdom, Hong Kong
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
Tang-Du HospitalRecruitingCarcinoma, Non-Small-Cell Lung | Neoplasm, Residual | Circulating Tumor DNA | Next-Generation Sequencing | Chemotherapy, AdjuvantChina
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Genentech, Inc.Completed
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
NovavaxDepartment of Health and Human ServicesCompletedCovid19 | SARS-CoV InfectionUnited States, Mexico, Puerto Rico
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Seagen Inc.CompletedHER2 Positive Breast CancersUnited States, Canada
-
NestléCompleted
-
Genentech, Inc.Completed
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
NovavaxDepartment of Health and Human ServicesCompleted
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, Belgium, Germany, Italy, United Kingdom, Netherlands
-
NovavaxActive, not recruitingCOVID-19Spain, United States, South Africa, Mexico, United Kingdom, Philippines, Colombia, Dominican Republic, Guatemala, Honduras
-
GlaxoSmithKlineRecruitingHepatitis BGermany, United Kingdom, Belgium
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Brain Cancer | Brain MetastasisUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerFrance, Italy, Spain, Hong Kong, United States, Canada, Mexico, Denmark, Germany, Portugal, Taiwan, Switzerland, Bulgaria, Korea, Republic of, Singapore, United Kingdom, Slovenia, Bosnia and Herzegovina, Russian Federation, Br... and more
-
Beijing Tiantan HospitalDuke UniversityUnknownGlioblastoma | High Grade Glioma | Glioma, Malignant | Glioma of BrainstemChina
-
GlaxoSmithKlineActive, not recruitingHerpes SimplexGermany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
-
GlaxoSmithKlineActive, not recruitingCytomegalovirus InfectionsUnited States
-
NovavaxCompleted
-
General Hospital of Shenyang Military RegionThe Third Xiangya Hospital of Central South UniversityCompleted
-
BiogenCompleted
-
Spectrum Pharmaceuticals, IncTerminatedBreast CancerUnited States
-
Rennes University HospitalRecruiting
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruiting
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingSalivary Gland Cancer | HER2 Gene MutationUnited States
-
Immune Response BioPharma, Inc.croUnknownMultiple SclerosisUnited States
-
EpimmuneUnknownLung CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Fractyl Health Inc.CompletedDiabetes Mellitus, Type 2 | Noninsulin-Dependent Diabetes MellitusUnited Kingdom, Belgium, Brazil, Italy, Netherlands